Doximity, Inc. $DOCS Shares Sold by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS lessened its holdings in Doximity, Inc. (NASDAQ:DOCS) by 6.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 34,100 shares of the company’s stock after selling 2,400 shares during the period. KLP Kapitalforvaltning AS’s holdings in Doximity were worth $2,092,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. GAMMA Investing LLC raised its stake in shares of Doximity by 5.9% in the 2nd quarter. GAMMA Investing LLC now owns 2,981 shares of the company’s stock valued at $183,000 after acquiring an additional 165 shares during the period. Amalgamated Bank raised its stake in shares of Doximity by 0.3% in the 1st quarter. Amalgamated Bank now owns 60,928 shares of the company’s stock valued at $3,536,000 after acquiring an additional 186 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Doximity by 0.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,978 shares of the company’s stock worth $2,262,000 after buying an additional 210 shares during the period. Greenleaf Trust increased its stake in Doximity by 5.4% during the 1st quarter. Greenleaf Trust now owns 4,492 shares of the company’s stock worth $261,000 after buying an additional 230 shares during the period. Finally, Spire Wealth Management increased its stake in Doximity by 73.2% during the 1st quarter. Spire Wealth Management now owns 615 shares of the company’s stock worth $36,000 after buying an additional 260 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Insider Activity

In other news, Director Kira Scherer Wampler sold 2,000 shares of Doximity stock in a transaction dated Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the transaction, the director directly owned 16,618 shares of the company’s stock, valued at approximately $948,721.62. The trade was a 10.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the completion of the transaction, the director directly owned 3,221 shares of the company’s stock, valued at $241,575. This trade represents a 86.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 32,000 shares of company stock valued at $2,281,680. Company insiders own 31.30% of the company’s stock.

Doximity Stock Performance

DOCS opened at $65.70 on Monday. The company has a 50-day moving average of $68.46 and a 200-day moving average of $60.96. The company has a market capitalization of $12.31 billion, a P/E ratio of 65.70, a PEG ratio of 4.10 and a beta of 1.38. Doximity, Inc. has a 1-year low of $40.87 and a 1-year high of $85.21.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. Doximity’s revenue was up 15.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, sell-side analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on DOCS shares. Truist Financial lifted their price target on shares of Doximity from $52.00 to $61.00 and gave the stock a “hold” rating in a research note on Thursday, July 17th. The Goldman Sachs Group set a $64.00 price target on shares of Doximity and gave the stock a “sell” rating in a research note on Wednesday, October 1st. JPMorgan Chase & Co. reaffirmed an “underweight” rating and set a $62.00 price target on shares of Doximity in a research note on Friday. Bank of America lifted their price target on shares of Doximity from $55.00 to $62.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 25th. Finally, Raymond James Financial set a $75.00 price target on shares of Doximity in a research note on Wednesday, September 10th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $69.37.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.